Gale Smith
Chief Tech/Sci/R&D Officer bei NOVAVAX, INC.
Profil
Dr. Gale E. Smith ist Chief Scientist & Senior Vice President-Discovery bei Novavax, Inc. Er erwarb seinen Bachelor-Abschluss an der University of North Dakota und seinen Doktortitel an der Texas A&M University.
Aktive Positionen von Gale Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Gale Smith
| Unternehmen | Position | Ende |
|---|---|---|
Protein Sciences Corp.
 Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Gale Smith
| Texas A&M University | Doctorate Degree |
| University of North Dakota | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Health Technology |
